Share this post on:

Product Name :
iHCK-37

Search keywords :
Tyrosine Protein Kinase HCK

drugId :
null

Target Vo:
Tyrosine-protein kinase HCK

Target Vo Short Name :
Tyrosine-protein kinase HCK

Moa_Name:
Tyrosine-protein kinase HCK inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Campinas, Brazil

Active Company_Name :
University Of Campinas, Brazil

Active Indication_Name:
Myelodysplastic Syndromes

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cyclin E1 Rabbit mAb Protocol
ATP citrate lyase Rabbit mAb manufacturer
GFAP Antibody (YA416): GFAP Antibody (YA416) is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to GFAP. It can be used for WB,IHC-P,IP,IF assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related